OPKO Health (NASDAQ:OPK) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
Pfizer and OPKO's Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency
Pfizer Inc. (NYSE:PFE) and OPKO Health, Inc.
Gainers
Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated global provider of energy infrastructure.
Toward the end of trading Monday, the Dow traded down 1.84% to 33,636.46 while the NASDAQ fell 1.83% to 13,517.61. The S&P also fell, dropping, 1.98% to 4,310.71.
Midway through trading Monday, the Dow traded down 3.09% to 33,205.52 while the NASDAQ fell 4.56% to 13,141.60. The S&P also fell, dropping, 3.82% to 4,230.05.
Gainers
Exterran Corporation (NYSE: EXTN) shares jumped 52.4% to $4.5720 after the company said it would merge with Enerflex to create a premier integrated global provider of energy infrastructure.
Today's 5 Stock Ideas:
Unilever (UL) - Shares rose following a media report that hedge fund Trian Partners has built a stake in the company.
Snap (SNAP) - Wedbush downgraded the stock from Outperform to